Harae Dx

Harae Dx

Developing a compact, portable, low-cost, fast, accurate and simple to use automated cancer detection system.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
investor investor

€0.0

round
investor

€0.0

round

N/A

Series A
Total Funding000k
Notes (0)
More about Harae Dx
Made with AI
Edit

Harae DX is a pioneering startup focused on revolutionizing cancer diagnostics through advanced artificial intelligence (AI) technology. The company specializes in developing highly compact, portable, and cost-effective automated systems for early cancer detection, specifically targeting breast cancer. Their innovative approach leverages a licensed panel of biomarkers—biological indicators that signal the presence of cancer—to provide rapid, accurate, and easy-to-use diagnostic solutions.

The company operates in the healthcare and medical diagnostics market, serving a wide range of clients including hospitals, clinics, and research institutions. By offering a solution that is both affordable and efficient, Harae DX aims to make early cancer detection accessible to a broader population, thereby improving patient outcomes and potentially saving lives.

Harae DX's business model is centered around the sale and licensing of its diagnostic systems and biomarker panels. The company generates revenue by selling these systems to healthcare providers and through licensing agreements with other medical technology companies. Additionally, they may explore partnerships and collaborations with research institutions and healthcare organizations to further expand their market reach and enhance their technological capabilities.

The team behind Harae DX is composed of seasoned entrepreneurs, engineers, and researchers with over 25 years of experience in AI and related fields. Key figures include Alan Wake, a PhD researcher with extensive experience in quantum physics and serial entrepreneurship, and Ali Muckadam, a seasoned engineer and former Director of Engineering at POC Medical Systems. Their collective expertise and innovative vision drive the company's mission to create a better future for humanity through cutting-edge cancer diagnostics.

In summary, Harae DX is at the forefront of next-generation cancer diagnostics, bridging the gap between healthcare IT and medical diagnostics to deliver rapid, accurate, and affordable cancer detection solutions.

Keywords: Cancer Diagnostics, AI Technology, Biomarkers, Portable Systems, Early Detection, Healthcare, Medical Devices, Innovation, Cost-effective, Rapid Testing.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads